Ashland (ASH)
NYSE:ASH
Want to see ASH full AI Analyst Report?
ASH Stock Chart & Stats
$58.52
-$1.29(-1.81%)
At close: 4:00 PM EST
$58.52
-$1.29(-1.81%)
Day’s Range― - ―
52-Week Range$46.30 - $67.20
Previous CloseN/A
Volume49.57K
Average Volume (3M)632.18K
Market Cap
$3.00B
Enterprise Value$3.79B
Total Cash (Recent Filing)$343.00M
Total Debt (Recent Filing)$1.48B
Price to Earnings (P/E)―
Beta1.03
Next Earnings
Jul 28, 2026EPS Estimate
1.11Next Dividend Ex-DateN/A
Dividend Yield2.79%
Share Statistics
EPS (TTM)-15.34
Shares Outstanding45,787,777
10 Day Avg. Volume536,791
30 Day Avg. Volume632,178
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.16
Price to Sales (P/S)1.21
P/FCF Ratio-550.97
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue2.09
Enterprise Value/Gross Profit8.30
Enterprise Value/Ebitda-12.88
Forecast
1Y Price Target
$63.22Price Target Upside8.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)3.63
Revenue Forecast (FY)$1.85B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent TTM operating cash flow (~$414M) and solid free cash flow (~$343M) provide durable internal funding. This strengthens liquidity, funds R&D and capex, supports deleveraging or opportunistic M&A, and cushions the business through profit volatility over the next several quarters.
Innovation And Commercialization MomentumThe Innovate and Globalize programs are already delivering incremental, higher-value sales and exceeded early targets. Recurring incremental revenue from new product launches and globalization supports margin recovery and structural revenue diversification across consumer and pharma end markets over the medium term.
Board & Governance StrengtheningAdding an experienced director with a track record leading a specialty materials company strengthens strategic oversight and execution capability. Improved board expertise can accelerate globalization, M&A discipline and operational fixes, making governance a structural positive for medium-term strategic delivery.
Bears Say
Deeply Negative Profitability And ReturnsLarge accounting losses and negative margins indicate the current business model is not generating returns on capital. Sustained negative profitability can erode equity, constrain reinvestment capacity, limit strategic optionality and force tougher cost or portfolio actions if not normalized in coming quarters.
Execution Issues At Hopewell & Plant DisruptionThe Hopewell scale‑up and Calvert City start‑up delays materially reduced expected manufacturing optimization (~$10–$12M) and hurt margins. Persistent yield and productivity shortfalls create a lasting cost overhang and delay expected structural savings until full ramp and reliability are demonstrably achieved.
Input Cost Pressure And Pricing LagSignificant exposure to energy and logistics inflation, combined with uneven pricing recovery, compresses margins across segments. If pricing actions lag or end‑market strength remains mixed, higher input costs can structurally depress operating margins and cash conversion over multiple quarters.
Ashland News
ASH FAQ
What was Ashland’s price range in the past 12 months?
Ashland lowest stock price was $46.30 and its highest was $67.20 in the past 12 months.
What is Ashland’s market cap?
Ashland’s market cap is $3.00B.
When is Ashland’s upcoming earnings report date?
Ashland’s upcoming earnings report date is Jul 28, 2026 which is in 45 days.
How were Ashland’s earnings last quarter?
Ashland released its earnings results on Apr 28, 2026. The company reported $0.91 earnings per share for the quarter, missing the consensus estimate of $0.958 by -$0.048.
Is Ashland overvalued?
According to Wall Street analysts Ashland’s price is currently Undervalued.
Does Ashland pay dividends?
Ashland pays a Quarterly dividend of $0.42 which represents an annual dividend yield of 2.79%. See more information on Ashland dividends here
What is Ashland’s EPS estimate?
Ashland’s EPS estimate is 1.11.
How many shares outstanding does Ashland have?
Ashland has 45,787,777 shares outstanding.
What happened to Ashland’s price movement after its last earnings report?
Ashland reported an EPS of $0.91 in its last earnings report, missing expectations of $0.958. Following the earnings report the stock price went down -13.772%.
Which hedge fund is a major shareholder of Ashland?
Currently, no hedge funds are holding shares in ASH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ashland Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$63.22 (8.04% Upside)
$63.22 (8.04% Upside)
Blogger Sentiment
Bullish
ASH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 169.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
15.37%
12-Months-Change
Fundamentals
Return on Equity
-37.54%
Trailing 12-Months
Asset Growth
-14.03%
Trailing 12-Months
Company Description
Ashland
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
ASH Company Deck
ASH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: underlying end‑market demand in consumer‑facing businesses (Life Sciences and Personal Care) and innovation/globalization momentum are clear positives — innovation has already exceeded targets and cash generation was strong. However, material internal execution issues (Calvert City outage, weather disruptions and the Hopewell HEC ramp) and margin compression meaningfully pressured near‑term results and led to a prudent trimming of guidance. Management emphasizes these operational items are internal and actionable while maintaining longer‑term cost‑saving targets and strategic paths to growth.View all ASH earnings summariesASH Stock 12 Month Forecast
Average Price Target
$63.22
▲(8.04% Upside)
Technical Analysis
Ownership Overview
0.52% Insiders
32.70% Mutual Funds
31.14% Other Institutional Investors
11.89% Public Companies and
Individual Investors